Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04152824 · ClinicalTrials.gov registry record · NA
Readiness Supportive Leadership Training
A NA study of Health Behavior and Well-being, sponsored by Oregon Health and Science University.
- Active
- Registry status
- NA
- Development phase
- 1,890
- Enrollment target
- 1
- Study location
NCT04152824: Active NA study of Health Behavior and Well-being, sponsored by Oregon Health and Science University.
NCT04152824 is a NA study of Health Behavior and Well-being that is active but no longer recruiting, run by Oregon Health and Science University. The registered enrollment target is 1,890 participants, below the 2,157-participant average among 65 other Health Behavior trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04152824, a NA study of Health Behavior and Well-being, is active but no longer recruiting, sponsored by Oregon Health and Science University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,890 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized controlled trial that assesses the effects of an evidence based, multi-component, leadership support intervention, Resilience-Supportive Leadership Training (RESULT), using accelerated learning strategies aimed at improving Service Member resilience and readiness in the military. The intervention is expected to increase perceptions of resilience-supportive behaviors, resilience indicators, and related behavioral health outcomes such as emotion regulation, connectedness, team cohesion, and psychological health following the training from the perspective of the Service Member.
Primary Outcome
Service member's perceptions of leadership emotional support behavior. Likert-type scale 1-5, with higher scores indicating greater support
Conditions Studied
Interventions
- BEHAVIORAL Resilience-Supportive Leadership Training (RESULT)
Study Locations (1)
Washington
- Joint Base Lewis McChord - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,890 participants |
| Start Date | 2019-09-02 |
| Est. Completion | 2025-08 |
| Phase | NA |
What the registry record for NCT04152824 still lists
NCT04152824 is an interventional study that assigns participants to a tested intervention. Its 1,890 participants enrollment target places it among the larger protocols in the corpus, below the 2,157-participant average among 65 other Health Behavior trials with a reported enrollment target (12% lower).
The record links to 2 conditions, with Health Behavior appearing as the primary indexed condition, and to 1 intervention - of which Resilience-Supportive Leadership Training (RESULT) is the first listed.
NCT04152824 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04152824 about?
NCT04152824 is a clinical study titled "Readiness Supportive Leadership Training". This study is a randomized controlled trial that assesses the effects of an evidence based, multi-component, leadership support intervention, Resilience-Supportive Leadership Training (RESULT), using accelerated learning strategies aimed at improving Service Member resilience and readiness in the mi...
What is the current status of trial NCT04152824?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,890 participants. The study started on 2019-09-02. Estimated completion is 2025-08.
What conditions does trial NCT04152824 study?
This clinical trial studies the following conditions: Health Behavior, Well-being.
What interventions are being tested in trial NCT04152824?
The interventions under investigation include: Resilience-Supportive Leadership Training (RESULT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04152824?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04152824 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04152824's enrollment target sits among peer trials
1,890 9th of 65 higher than 57 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Validation Study of Bioelectronics
RECRUITING · NA
-
A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07308717 · 1,896 participants · Phase 4
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
- NCT06438640 · 1,881 participants · NA
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
- NCT05712200 · 1,900 participants · Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI